IU report supplies close examination of EU's reformed chemicals law

U.S. industry and environmental groups agree that the Toxic Substances Control Act (TSCA) of 1976 needs to be modernized to better protect public health and the environment. However, there is no consensus on what the reform should look like.

A new report from Indiana University supplies a close examination of the European Union's reformed chemicals law REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), which went into effect in 2006.

After reviewing data and interviewing key stakeholders, including manufacturers, importers and REACH experts, researchers from the IU School of Public and Environmental Affairs and the IU European Union Center have released "Regulating Industrial Chemicals: Lessons for U.S. Policy Makers From the European Union's REACH Program."

"As the U.S. Congress considers whether and how to modernize TSCA, much can be learned from the European experience with REACH," said SPEA Dean John D. Graham, a co-author of the report. "Some aspects of REACH are innovative and promising, while others are overly burdensome and complicated."

While the report examines all areas of REACH, the primary focus is on the program's chemical registration process. REACH shifts the burden of proving safety from the government to industry. REACH's key principle -- "no data, no market" -- compels manufacturers of substances, producers of articles and importers to supply regulators a minimum safety-related data set for a large number of existing chemicals.

"One of our most important conclusions is that there needs to be a clear and consistent definition of 'safety' throughout any new chemical regulatory program," said the report's lead author, Adam Abelkop, a doctoral student in SPEA.

Researchers have identified several aspects of the EU program that merit consideration by U.S. policymakers as well as areas that could be refined and modified to be more transparent, simplified and suitable for the U.S. context. Highlights of the report indicate that a REACH-like system in the United States should focus on opportunities to reduce risks to human health and the environment. In addition, new legislation should provide clarification about critical standards, processes and tools while lessening unnecessary burdens on industry by allowing for mutual, cross-Atlantic recognition of registration dossiers.

"This suggestion would ease obligations on companies that do business on both sides of the Atlantic and would lessen the work of the regulators," said REACH consultant Agnes Botos, co-author of the report and a Central European University doctoral student. "That is why it would be worth doing a more detailed analysis about this topic."

According to SPEA professor Lois Wise, co-author of the report and director of the European Union Center and West European Studies at IU, REACH offers an alternative approach to the process of chemical regulation and control providing a greater understanding of how regulatory processes work.

"Our interest is in the extent to which the European experience implementing this complicated and innovative piece of legislation can inform efforts to revise TSCA," she said. "This study, examining the process of REACH implementation, provides useful insight for policymakers."

On March 2, SPEA and the European Union Center will host an invitation-only seminar in Washington, D.C., that includes a panel of international experts who will discuss Europe's early experiences with REACH and issues related to TSCA reform.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study links e-cigarette use to increased respiratory symptoms